These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29269262)

  • 1. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy.
    Li H; Sagar AP; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():1-7. PubMed ID: 29269262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder.
    Li H; Sagar AP; Kéri S
    J Affect Disord; 2018 Dec; 241():305-310. PubMed ID: 30142589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
    Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
    JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.
    Setiawan E; Attwells S; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Xu C; Sharma S; Kish S; Houle S; Meyer JH
    Lancet Psychiatry; 2018 Apr; 5(4):339-347. PubMed ID: 29496589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
    Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study.
    Holmes SE; Hinz R; Conen S; Gregory CJ; Matthews JC; Anton-Rodriguez JM; Gerhard A; Talbot PS
    Biol Psychiatry; 2018 Jan; 83(1):61-69. PubMed ID: 28939116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [
    Hafizi S; Da Silva T; Gerritsen C; Kiang M; Bagby RM; Prce I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Neuropsychopharmacology; 2017 Dec; 42(13):2474-2481. PubMed ID: 28604733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
    Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
    Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.
    Braga J; Lepra M; Kish SJ; Rusjan PM; Nasser Z; Verhoeff N; Vasdev N; Bagby M; Boileau I; Husain MI; Kolla N; Garcia A; Chao T; Mizrahi R; Faiz K; Vieira EL; Meyer JH
    JAMA Psychiatry; 2023 Aug; 80(8):787-795. PubMed ID: 37256580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging translocator protein (TSPO) in autism spectrum disorder.
    Simpson D; Gharehgazlou A; Da Silva T; Labrie-Cleary C; Wilson AA; Meyer JH; Mizrahi R; Rusjan PM
    Neuropsychopharmacology; 2022 Jun; 47(7):1421-1427. PubMed ID: 35383319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.
    Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
    Biol Psychiatry; 2018 Sep; 84(6):433-442. PubMed ID: 29653835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
    Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
    Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.
    Attwells S; Setiawan E; Wilson AA; Rusjan PM; Mizrahi R; Miler L; Xu C; Richter MA; Kahn A; Kish SJ; Houle S; Ravindran L; Meyer JH
    JAMA Psychiatry; 2017 Aug; 74(8):833-840. PubMed ID: 28636705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
    Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicating predictive serum correlates of greater translocator protein distribution volume in brain.
    Attwells S; Setiawan E; Wilson AA; Rusjan PM; Miler L; Xu C; Hutton C; Husain MI; Kish S; Vasdev N; Houle S; Meyer JH
    Neuropsychopharmacology; 2020 May; 45(6):925-931. PubMed ID: 31683271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
    Enache D; Pariante CM; Mondelli V
    Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder.
    Attwells S; Setiawan E; Rusjan PM; Xu C; Hutton C; Rafiei D; Varughese B; Kahn A; Kish SJ; Vasdev N; Houle S; Meyer JH
    Biol Psychiatry; 2020 Oct; 88(8):649-656. PubMed ID: 32402468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.
    Hafizi S; Da Silva T; Meyer JH; Kiang M; Houle S; Remington G; Prce I; Wilson AA; Rusjan PM; Sailasuta N; Mizrahi R
    Neuropsychopharmacology; 2018 Jul; 43(8):1700-1705. PubMed ID: 29748630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study.
    Dahoun T; Calcia MA; Veronese M; Bloomfield P; Reis Marques T; Turkheimer F; Howes OD
    Brain Behav Immun; 2019 Aug; 80():742-750. PubMed ID: 31112791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
    Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
    J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.